New research from NewYork-Presbyterian and Weill Cornell Medicine identified economic and social conditions impacting individual and group differences in health status, known as social determinants of health.
A team led by investigators at Weill Cornell Medicine and NewYork-Presbyterian has used advanced technology and analytics to map the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases.
Mathematical modeling by Weill Cornell Medicine is helping to guide New York state and New York City leaders as they make decisions that could affect the trajectory of the COVID-19 pandemic.
Cornell researchers in fiber science and apparel design are putting their knowledge and energies into keeping health care personnel on the front lines of the COVID-19 pandemic from becoming patients themselves.
Fresh from Cornell AgriTech, the newest grape tomato – Moonbeam – has joined a constellation of heirloom-style tomatoes in the 2020 High Mowing Organic Seeds catalog Nov. 1.
Home health care workers in New York City faced increased risks to their physical, mental and financial well-being while providing essential care to patients early in the COVID-19 pandemic, according to researchers.
Marcos Simoes-Costa in the Department of Molecular Biology and Genetics, and Dan A. Landau with Weill Cornell Medicine have both been awarded $600,000 from the Sontag Foundation to advance their research into brain cancer.
The Cornell Veterinary Biobank has received a $2.5 million federal grant to process, store and distribute biological samples for the Dog Aging Project, a massive national effort to study aging in dogs – and humans.
Sam Quinones, a former reporter for the Los Angeles Times known for covering immigration, drug trafficking and gang violence, will speak on the origins and impacts of the opioid epidemic Wednesday, Nov. 7, in Call Auditorium.